The Study on Regulation for the Distribution of Metastatic Cervical Lymph Nodes of Nasopharyngeal Carcinoma
Y Sun,T Lu,J Ma,Y Huang,Y Wang,L Tang,X Deng
DOI: https://doi.org/10.1016/j.ijrobp.2005.07.620
2005-01-01
Abstract:Purpose/Objective: Rational definition of the cervical target delineation is much more important in the conformal radiotherapy of nasopharyngeal carcinoma (NPC). Our study is focus on exploring the regulation for the distribution of metastatic cervical lymph nodes of NPC and recommending the delineation of clinical target volume of the neck for three-dimensional conformal radiotherapy (3D-CRT) and intensive modulated radiotherapy (IMRT) in NPC. Materials/Methods: From Jan. 2003 to Jun. 2004, a total of 512 consecutive patients presented with untreated nondisseminated NPC and received enhanced transversal CT scan of the head and neck at the Department of Radiation Oncology, Cancer Center, Sun Yat-sen University. Two cases were excluded from this study because of the diagnosis of adenocarcinoma. Of the eligible 510 patients, there were 377 male and 133 female patients, with a male:female ratio of 2.8:1. The median age was 46 years (range 13 to 75). Histologically, 98.8% of the patients had World Health Organization (WHO) type II or type III, the rest (1.2%) had WHO type I. The T stage distribution according to the AJCC/UICC (2002) Staging System was as follows: T1 12.4%, T2a 2.0%, T2b 52.0%, T3 21.0%, T4 12.7%. The N stage distribution was: N0 35.9%, N1 33.1%, N2 29.0%, N3a 4.5%, N3b 7.5%. The clinical stage distribution was as follows: stage I 7.5%, IIa 1.2%, IIb 36.3%, III 31.8%, IVa 11.4% and IVb 12.0%. Nodes were considered abnormal on CT criteria of size with a axial short diameter no less than 10mm but 11mm for level IIa, necrosis, extracapsular spread and groups. The total cervical was divided into six levels according to the RTOG guidelines proposed in 2003. The enlargement of retropharyngeal lymph node was defined as primary tumor and thus was classified as T stage. Results: Of the 510 patients, 410 (80.4%) showed either retropharyngeal or cervical lymphadenopathy at presentation, and 244 (47.8%) showed both of them. Of the 327 neck positive cases, the node involvement was unilateral in 63.3% and bilateral in 36.7% patients. Of the 327 cases with retropharyngeal lymphadenopathy, 51.1% were unilateral and 48.9% were bilateral. Of the total 510 cases, The involvement of level I, II, III, IV, V and retropharyngeal node was 2.0%, 63.3%, 29.0%, 6.1%, 8.8% and 64.1% in all of the patients, while it was 3.1%, 98.8%, 45.3%, 9.5%, 13.8% and 74.6% in the N+ cases. Level Ia and level VI were never involved in this study. There were 83 (25.4%, 83/327) patients presented with cervical enlargement but without retropharyngeal lymphadenopathy. There were four cases (2.7%, 4/148) showed the involvement of level III, but not presented the involvement of level II, and there were only two cases (6.5%, 2/31) showed the involvement of level IV without the involvement of level III. Level II were all involved in the patients who presented the involvement of level IV or level V.83 cases with N+ showed involvement of the area beyond CTV for the neck of N0 recommended by RTOG. The limitation of the recommended CTV used for NPC with node positive existed in the cranial border of level II, the caudual border of level IV and posterior border of the level V. Conclusions: The retropharyngeal node, level II, and level III were the most frequently involved area in NPC. Level Ia and level VI were never involved, and level Ib were seldom involved in this study. The cervical node involvement of NPC is spread orderly down the neck, and the incidence of skip metastasis was lower as 2.7% to 6.5%. There are few cases with positive nodes beyond CTV for the neck of N0 recommended by RTOG. Our data is helpful for the delineation of cervical target for the 3D-CRT and IMRT of NPC in the future.